LANTERN PHARMA INC. (LTRN)

Import this data to Google Sheets with:

=jivedata("LTRN","financials")

Full statements spill as a table. For one cell: =jivedata("LTRN","Revenue") or =jivedata("LTRN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

LANTERN PHARMA INC.

LTRN • CIK 0001763950

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
General and Administrative Expense	$5,983.255	$6,090.747	$6,464.371	$6,768.379
Research and Development Expense	$11,894.315	$16,125.69	$11,514.123	$8,697.52
Operating Income (Loss)	$-17,877.57	$-22,216.437	$-17,978.494	$-15,465.899
Operating Expenses	$17,877.57	$22,216.437	$17,978.494	$15,465.899
Interest Income, Other	$765.388	$742.355	$437.931	$245.635
Other Nonoperating Income (Expense)	$1,150.648	$692.869	$421.125	$176.368
Net Income (Loss) Attributable to Parent	$-15,961.534	$-20,781.213	$-17,119.438	$-18,652.935
Weighted Average Number of Shares Outstanding, Basic	10,842,365	10,762,319	10,898,175	11,954,785

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$21,937.749	$7,511.079	$4,422.838	$6,660.17
Marketable Securities, Current	$19,364.923	$16,501.984	$5,696.386	$701.085
Property, Plant and Equipment, Net	$52.127	$47.44	$31.875	$24.271
Prepaid Expense and Other Assets, Current	$2,038.653	$1,234.566	$683.948	$1,097.664
Operating Lease, Right-of-Use Asset	$228.295	$239.985	$75.595	$38.242
Assets, Current	$43,341.325	$25,247.629	$10,803.172	$8,458.919
Deferred Costs, Noncurrent	—	—	$88.431	$54.827
Other Assets, Noncurrent	$25.869	$36.738	$36.738	$26.09
Assets	$43,647.616	$25,571.792	$11,035.811	$8,602.349
Operating Lease, Liability, Noncurrent	$61.496	$52.843	$52.843	$13.524
Liabilities	$2,739.682	$4,384.018	$4,501.587	$11,819.601
Accounts Payable and Accrued Liabilities, Current	$2,505.211	$4,140.361	$4,423.048	$4,282.797
Operating Lease, Liability, Current	$172.975	$190.814	$78.539	$39.715
Liabilities, Current	$2,678.186	$4,331.175	$4,501.587	$4,322.512
Common Stock, Value, Issued	$1.072	$1.078	$1.125	$1.276
Additional Paid in Capital	$96,258.726	$97,058.323	$99,652.724	$100,367.581
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-107.46	$153.99	$25.43	$-39.759
Retained Earnings (Accumulated Deficit)	$-55,244.404	$-76,025.617	$-93,145.055	$-103,546.35
Stockholders' Equity Attributable to Parent	$40,907.934	$21,187.774	$6,534.224	$-3,217.252
Preferred Stock, Shares Authorized	1,000,000	1,000,000	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	25,000,000	25,000,000	25,000,000	25,000,000
Common Stock, Shares, Issued	10,721,192	10,784,725	11,254,697	12,759,146
Operating Lease, Liability	$234.471	$243.657	$78.539	$39.715

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-15,961.534	$-20,781.213	$-17,119.438	$-18,652.935
Net Cash Provided by (Used in) Operating Activities	$-14,346.548	$-17,813.201	$-15,676.98	$-14,077.633
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-28.462	$-49.547	$33.426	$19.62
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-15,805.217	$-14,426.67	$-3,088.241	$598.762
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$21,937.749	$7,511.079	$4,422.838	$2,963.032
Depreciation, Depletion and Amortization, Nonproduction	—	$17.282	$17.28	$15.809
Payments to Acquire Property, Plant, and Equipment	$18.734	$12.595	$1.715	$1.715
Investment Income, Net, Amortization of Discount and Premium	$173.086	$238.574	$196.427	$83.721
Payments to Acquire Marketable Securities	$8,196.143	$17,275.68	$14,721.983	$14,721.983
Other Noncash Expense	$160.228	$173.211	$189.897	$130.505
Proceeds from Sale and Maturity of Marketable Securities	$7,284.667	$20,657.643	$25,780.771	$15,448.677
Issuance of Stock and Warrants for Services or Claims	—	—	$366.9	$366.9
Net Cash Provided by (Used in) Investing Activities	$-930.21	$3,369.368	$11,057.073	$9,166.834
Employee Benefit and Share-based Payment Arrangement, Noncash	—	$732.893	$650.877	$766.042
Foreign Currency Transaction Gain (Loss), before Tax	$-11.5	$-219.729	$157.965	$109.236
Debt Securities, Available-for-sale, Realized Gain (Loss)	$-115.84	$9.065	$22.408	$22.408
Equity Securities, FV-NI, Realized Loss	—	—	$264.913	$161.627
Unrealized Gain (Loss) on Investments	$119.65	$155.624	$305.887	$106.285
IncreaseDecreaseInOperatingLeaseLiability	$-159.255	$-175.715	$-190.625	$-130.831
Proceeds from Stock Options Exercised	—	—	$13.442	$13.442
Increase (Decrease) in Prepaid Expense and Other Assets	$-941.44	$-778.304	$-554.095	$-203.513
Proceeds from Warrant Exercises	—	$66.71	$66.71	$66.71
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-236.181	$1,636.44	$271.808	$-582.972
Proceeds from Issuance of Common Stock	—	—	$1,624.547	$1,624.547
Increase (Decrease) in Other Operating Assets	$7.98	$10.869	$10.869	—
Payments of Stock Issuance Costs	—	—	$139.749	$139.749
Net Cash Provided by (Used in) Financing Activities	$-499.997	$66.71	$1,498.24	$1,498.24
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$141.989	$348.623	$78.351	$78.351

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("LTRN","financials")

Full statements spill as a table. For one cell: =jivedata("LTRN","Revenue") or =jivedata("LTRN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.